The drugmaker said UBT251 achieved mean body weight reduction of up to 9.8% after a 24-week trial.
As deaths from diabetes start to rival those from infectious threats like malaria, a new form of the condition linked to ...
In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...
Diabetes is currently the seventh leading cause of death in the country and an ongoing issue across East Texas. To raise ...
Novo Nordisk and its Chinese partner have reported another midphase win for their triple-G candidate, sharing diabetes data ...
The first-in-class injectable could be the next big thing in diabetes and obesity treatment.
New program delivers family-centered diabetes education, clinical guidance, and device support for pediatric patients ...
Type 2 diabetes is alarming doctors as it's increasingly diagnosed in Indian children and teens, often linked to rising ...
Dr. Saraswathi Saiprasad, an endocrinologist with Baylor Scott & White, explains Latent Autoimmune Diabetes (LADA), a ...
The ICMR-National Institute of Nutrition has developed a poly-herbal extract that goes beyond blood sugar control to target ...